Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 349

Results For "UST"

3784 News Found

Indigenous technology will help reduce dependence on imports: Dr Singh
Digitisation | September 03, 2021

Indigenous technology will help reduce dependence on imports: Dr Singh

Union Minister addresses the 13th CII Global MedTech Summit on the sunrise medical devices sector in India


Covid-19 vaccine clinical trial for people with autoimmune disease
Drug Approval | September 03, 2021

Covid-19 vaccine clinical trial for people with autoimmune disease

Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study


Novartis signs world’s first agreement with NHS, UK
News | September 03, 2021

Novartis signs world’s first agreement with NHS, UK

The agreement follows positive NICE recommendation and commits to deliver Leqvio (inclisiran) access via a population health management approach identifying eligible patients across England


CII awards Excellence in Energy efficiency to Sai Life Sciences API unit
Sustainability | September 03, 2021

CII awards Excellence in Energy efficiency to Sai Life Sciences API unit

The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL


Digital adoption in healthcare will see exponential growth: Wipro GE study
Healthcare | September 03, 2021

Digital adoption in healthcare will see exponential growth: Wipro GE study

Key trends indicate that AI-based solutions, cloud-based healthcare solutions and digital transformations will be the key in the years to come.


Phase 2 of Covaxin intranasal trials begin in Kanpur
Biotech | September 02, 2021

Phase 2 of Covaxin intranasal trials begin in Kanpur

The vaccine is designed to neutralise the virus in the nostril itself and prevent it from penetrating deep down into the respiratory tract


Sun Pharma Advanced Research Company gets board approval to raise Rs 1,800 crore
News | September 02, 2021

Sun Pharma Advanced Research Company gets board approval to raise Rs 1,800 crore

At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.


Janssen announces U.S. FDA approval of Invega Hafyera
Drug Approval | September 02, 2021

Janssen announces U.S. FDA approval of Invega Hafyera

Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months


Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary
News | September 02, 2021

Morpen Laboratories to transfer its medical devices business to a wholly owned subsidiary

The revenues and profits derived from the new subsidiary will be consolidated in the parent company


Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage
News | September 01, 2021

Abbott launch room-temperature carbetocin in India for Postpartum Haemorrhage

PPH is associated with almost 20 per cent of maternal mortality in India